INS and bacterial pneumonia: The cumulative duration (<90, 90–179, >179 days) of insulin use had significantly increased risks of hospitalization for COPD, bacterial pneumonia, and IMV than insulin no-use, and longer cumulative insulin use appeared to increase the risk of these outcomes (Table 3).